Credit score: Unsplash/CC0 Public Area
A brand new research of greater than 2,900 sufferers offers proof that it is doubtless finest to make use of as little corticosteroid medication as potential when treating individuals who have lupus pericarditis, a standard coronary heart complication of the autoimmune illness systemic lupus erythematosus (SLE).
This research, led by Johns Hopkins Medication cardiologists and rheumatologists, say their evaluation of information affirms that utilizing steroids to curb coronary heart irritation and different painful signs for lupus sufferers can also be a threat issue for recurring pericarditis, a probably harmful irritation of the saclike membrane that encases and protects the center.
Outcomes of this research are revealed in JAMA Community Open.
In response to the American Coronary heart Affiliation, pericarditis is outlined as irritation of the pericardium, a sac-like construction with two skinny layers of tissue that encompass the center to carry it in place and assist shield it. Pericarditis sometimes presents as chest ache that may be exacerbated by mendacity flat and improved by leaning ahead. This ache can final anyplace from a couple of days to a number of months. Remedy choices for pericarditis embrace use of colchicine—an anti-inflammatory medicine that forestalls the recurrence of pericarditis—and corticosteroids.
Pericarditis happens in 15% to 30% of sufferers with SLE, a persistent autoimmune illness that causes the physique’s immune system to assault its personal tissues.
“It is well known that in the general population, one-fifth of patients who experience pericarditis end up experiencing one or more recurrences. Surprisingly, even though pericarditis is the most common cardiac complication of lupus, we could not find any information on recurrent of pericarditis in this patient population,” says Dr. Luigi Adamo, M.D., P.H.D., director of Cardiac Immunology at Johns Hopkins College and co-senior creator of this research.
Researchers got down to handle this hole in data and study the chance elements contributing to the recurrence.
For the brand new evaluation, researchers used information gathered among the many Hopkins Lupus Cohort, a big ongoing research group that features data on 2,931 sufferers recognized with SLE between 1988 to 2023 and the investigators targeted on information from 590 sufferers additionally recognized with pericarditis. Pericarditis within the information set was recognized utilizing the Security of Estrogens in Lupus Erythematosus Nationwide Evaluation—SLE Illness Exercise Index (SELENA-SLEDAI), a normal device within the evaluation of SLE scientific exercise.
Examine outcomes confirmed that 20% of sufferers with lupus who skilled pericarditis had a recurrence. Recurrent pericarditis was most prevalent amongst sufferers throughout the first yr of pericarditis onset, with recurrence reducing within the following years. Youthful sufferers and people with uncontrolled illness had been at larger threat of recurrence. It was famous that oral prednisone remedy, a device regularly used to deal with pericarditis in sufferers with autoimmune ailments, was related to the next likelihood of pericarditis recurrence in sufferers with SLE.
“The cardiology literature has shown that use of corticosteroids increases the risk of recurrent pericarditis in the general population. Nevertheless, steroids are very frequently used by rheumatologists to treat lupus pericarditis. Therefore, the findings from this study underscore the importance of minimizing oral corticosteroid use in patients with lupus and indicate the need for alternative strategies,” stated Andrea Fava, M.D., a rheumatologist who focuses on care of sufferers with lupus and co-senior creator of the research.
Different Johns Hopkins researchers who contributed to the research are Yoo Jin Kim, Jana Lovell, Daniel Goldman, and Michelle Petri.
Extra data:
Yoo Jin Kim et al, Incidence and Elements Related With Recurrent Pericarditis in Lupus, JAMA Community Open (2025). DOI: 10.1001/jamanetworkopen.2024.61610
Offered by
Johns Hopkins College Faculty of Medication
Quotation:
New research helps warning relating to use of steroids for sufferers with lupus (2025, February 26)
retrieved 26 February 2025
from https://medicalxpress.com/information/2025-02-caution-steroids-patients-lupus.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.
